Saniona, FPWR Call Attention to Planned Phase 2b Tesomet Clinical Trial

Saniona, FPWR Call Attention to Planned Phase 2b Tesomet Clinical Trial

292318

Saniona, FPWR Call Attention to Planned Phase 2b Tesomet Clinical Trial

The Foundation for Prader-Willi Research (FPWR) and Saniona are working together to inform patients and their families of an upcoming Phase 2b trial evaluating Tesomet as a potential treatment of Prader-Willi syndrome (PWS), and to best ensure community involvement. Initiation of this study, which follows positive findings in a Phase 2a trial in adults and adolescents with PWS, is expected by June. “There are currently no approved treatment options to manage hyperphagia, the uncontrollable hunger that is…

You must be logged in to read/download the full post.